SCHEMBL16303318

SCHEMBL16303318

CO/N=C/c1ccnc(CNCCCN(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 2/20 0.38
▸ SIRT2 Q8IXJ6 4/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ FERMT2 Q96AC1 1/20 0.36
▸ KDM5B Q9UGL1 6/20 0.35
▸ KDM5A P29375 5/20 0.35
▸ KDM5C P41229 5/20 0.35
▸ KDM4C Q9H3R0 2/20 0.35
▸ SCN8A Q9UQD0 1/20 0.35
▸ KDM6B O15054 1/20 0.35
▸ KDM4A O75164 1/20 0.35
▸ KDM2B Q8NHM5 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KDM5D Q9BY66 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16292516 1.00 TERT (0.38) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL16293473 0.84 TERT (0.39) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL16305531 0.84 TERT (0.39) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL17984971 0.84 CHRM2 (0.40) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL16305536 0.84 CHRM2 (0.40) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL17984983 0.82 CHRM2 (0.38) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL18017098 0.81 SIRT2 (0.42) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL16292333 0.79 KDM5B (0.40) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL15994045 0.78 CHRM2 (0.36) TERTSIRT2ALOX15CHRM2FERMT2
SCHEMBL15994044 0.78 CHRM2 (0.36) TERTSIRT2ALOX15CHRM2FERMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961736-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2018-04-11 — — EP claimed
US-9650339-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2017-05-16 — — US claimed
US-20160237037-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2016-08-18 — — US claimed
EP-2961736-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2018-04-11 — — EP disclosed
EP-3170811-A1 ETHYL PYRIDINE-4-CARBOXYLATE COMPOUND AS INHIBITOR OF HISTONE DEMETHYLASES Gilead Sciences, Inc. (US) 2017-05-24 — — EP disclosed
US-9650339-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2017-05-16 — — US disclosed
US-9221801-B2 Inhibitors of histone demethylases EPITHERAPEUTICS APS (DK) 2015-12-29 — — US disclosed
US-9221801-B2 Inhibitors of histone demethylases EPITHERAPEUTICS APS (DK) 2015-12-29 — — US disclosed
US-20140371214-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed
US-20140371214-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371214-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM1A, KDM3A TERT 1180/4885SIRT2 592/4885ALOX15 1831/4885
US-20160237037-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM1A, KDM3A TERT 1180/4885SIRT2 592/4885ALOX15 1831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback